Fennec Pharmaceuticals Inc FENC:NASDAQ

Last Price$6.78Cboe Real-Time Last Sale as of 1:22PM ET 8/15/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.16(2.31%)
Bid (Size)$6.84 (100)
Ask (Size)$6.94 (100)
Day Low / High$6.76 - 6.98
Volume42.9 K

Fennec Pharmaceuticals Resubmits New Drug Application for Pedmark

6:24AM ET 3/24/2022 MT Newswires
Fennec Pharmaceuticals (FENC) said Thursday it has resubmitted its new drug application for Pedmark to the US Food and Drug Administration.

Pedmark is a formulation of sodium thiosulfate meant for preventing platinum-induced ototoxicity in pediatric patients with localized, non-metastatic, solid tumors, the company said.

The FDA had refused to accept the Pedmark new drug application in November due to certain manufacturing deficiencies, according to a statement.

FENC stock price gained 4.9% in after-hours trading on Wednesday.